FDA approves Bayer's recombinant Factor VIII for hemophilia A

FDA approved a BLA from Bayer AG (Xetra:BAYN) for Jivi damoctocog

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE